Skip to content

Interest of Measuring Lung Elasticity ELASTOgraphy in the Fetus in the Case of PreMAture Childbirth Threat

Interest of Measuring Lung Elasticity ELASTOgraphy in the Fetus in the Case of PreMAture Childbirth Threat

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02870608
Acronym
ELASTOMAP
Enrollment
103
Registered
2016-08-17
Start date
2016-04-30
Completion date
2017-03-14
Last updated
2018-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstetric Labor, Premature, Pregnancy Complications

Keywords

Elastography

Brief summary

The objective of the study was to evaluated the feasibility and reproducibility of the measurement of lung elasticity report / fetal liver according to gestational age in a group of patients with a normal course of pregnancy and in a group of Patients at risk of preterm delivery.

Interventions

Sponsors

Centre Hospitalier Universitaire de Besancon
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

for control group : * major pregnant women * singleton pregnancy Inclusion Criteria for control group : * major pregnant women * singleton pregnancy * hospitalized for threatened premature birth between 24 and 34 WA * Indication of a cure corticosteroid betamethasone

Exclusion criteria

* maternal conditions of pregnancy: diabetes gestational, pregnancy-induced hypertension, preeclampsia * fetal lung diseases

Design outcomes

Primary

MeasureTime frameDescription
Evolution over 48 hours of the fetal lung elasticity coefficient measure in kilopascals (kPa) (compared to the fetal liver)For pretern larbor group: day of hospitalization for preterm labor, then 2 days later. For control group, both measurements at 2-day intervalsThe dates of elastography exams controls patients will be distributed a week of amenorrhea (WA) between 24 and 34 WA.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 25, 2026